compound introduction
Information GCN2iB GCN2iB is an ATP-competitive serine/threonine-protein kinase general control nonderepressible 2 (GCN2) inhibitor with IC50 of 2.4 nM. Targets GCN2 (Cell-free assay) 2.4 nM Cell Research(from reference) Cell lines：Pancreatic cancer cells, CCRF-CEM cells, MEF cells (GCN2-WT or -KO), CCRF-CEM, MV-4-11, SU.86.86 cells Concentrations：37 nM, 110 nM, 330 nM, 1.0 μM Incubation Time：4 h, 72 h Product Application： GCN2iB is an intermediate used in the preparation of heterocyclic compounds as GCN2 inhibitors.
